Skip to content
10-K

Annual Report

Elicio Therapeutics, Inc. ELTX

0001601485-26-000027

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 10, 2026 18.4M sh
Shares Diluted FY 2025 · Dec 31, 2025 15.31M sh
Shares Diluted FY 2025 · Dec 31, 2024 12.2M sh
Capex FY 2025 · Dec 31, 2025 $16K
Capex FY 2025 · Dec 31, 2024 $87K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$36.95M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$37.07M
Long Term Debt FY 2025 · Dec 31, 2025 $9.41M
Long Term Debt FY 2025 · Dec 31, 2024 $20.03M
Cash And Equivalents FY 2025 · Dec 31, 2025 $18.56M
Cash And Equivalents FY 2025 · Dec 31, 2024 $17.62M
Stockholders Equity FY 2025 · Dec 31, 2025 $1.64M
Stockholders Equity FY 2025 · Dec 31, 2024 −$11.31M
Stockholders Equity FY 2025 · Dec 31, 2023 $11.37M
Current Liabilities FY 2025 · Dec 31, 2025 $8.11M
Current Liabilities FY 2025 · Dec 31, 2024 $11.52M
Total Liabilities FY 2025 · Dec 31, 2025 $24.23M
Total Liabilities FY 2025 · Dec 31, 2024 $39.49M
Current Assets FY 2025 · Dec 31, 2025 $19.31M
Current Assets FY 2025 · Dec 31, 2024 $20.69M
Total Assets FY 2025 · Dec 31, 2025 $25.86M
Total Assets FY 2025 · Dec 31, 2024 $28.18M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.58
Eps Diluted FY 2025 · Dec 31, 2024 −$4.25
Eps Basic FY 2025 · Dec 31, 2025 −$2.58
Eps Basic FY 2025 · Dec 31, 2024 −$4.25
Sga Expense FY 2025 · Dec 31, 2025 $12.81M
Sga Expense FY 2025 · Dec 31, 2024 $11.33M
Rd Expense FY 2025 · Dec 31, 2025 $24.9M
Rd Expense FY 2025 · Dec 31, 2024 $33.66M
Net Income FY 2025 · Dec 31, 2025 −$39.57M
Net Income FY 2025 · Dec 31, 2024 −$51.9M
Operating Income FY 2025 · Dec 31, 2025 −$37.71M
Operating Income FY 2025 · Dec 31, 2024 −$44.99M